Comparing the number of shares on its own is irrelevant. Where the number of shares becomes relevant is determining market valuation (share price multiplied by number of shares) etc. You need another element, usually a financial one, to get anything meaningful.
- Forums
- ASX - By Stock
- LYC vs MP
LYC
lynas rare earths limited
Add to My Watchlist
3.48%
!
$8.88

Comparing the number of shares on its own is irrelevant. Where...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.88 |
Change
-0.320(3.48%) |
Mkt cap ! $8.372B |
Open | High | Low | Value | Volume |
$9.44 | $9.44 | $8.87 | $40.71M | 4.502M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 11540 | $8.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.88 | 6743 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 15153 | 8.890 |
27 | 17899 | 8.880 |
14 | 15341 | 8.870 |
11 | 15200 | 8.860 |
10 | 13045 | 8.850 |
Price($) | Vol. | No. |
---|---|---|
8.900 | 2239 | 18 |
8.910 | 8829 | 20 |
8.920 | 9273 | 11 |
8.930 | 10099 | 10 |
8.940 | 9210 | 9 |
Last trade - 15.36pm 27/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online